Independent provider comparison
Updated September 27, 2026
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.
The short decision
Choose Embody if you want a straightforward compounded injection with the lower published one-month commitment. It lists one-month semaglutide at $79 and tirzepatide at $129, including care and shipping. Choose IVIM Health if a clinician-supervised microdose program is your specific goal. IVIM's lowest published microdose semaglutide rate is $75 per month on a four- or six-month term, plus a separate $74.99 monthly program fee, for a $149.99 monthly equivalent. These are different doses and care models, not interchangeable price quotes. IVIM also offers separate brand-name and oral treatment paths.
Embody pays us a commission through our links. IVIM Health is included as an editorial comparison and does not currently pay us through this site. That difference does not set scores or decide which care model fits a reader. How we make money.
Our pick for a lower one-month cash-pay entry
Embody lists one month of compounded semaglutide at $79 and tirzepatide at $129, with medication, clinical review, coaching and shipping included.
Treatment requires clinical approval. The medication is compounded and not FDA approved, and payments are normally non-refundable after checkout.
Explore Embody's plans Compare Embody plans and care
Choose IVIM for a dedicated lower-dose program
IVIM publishes two-, four- and six-month microdose programs with a video consultation, individualized plan, weekly check-ins and app access.
Its $75 medication floor excludes the separate $74.99 monthly program fee and requires a four- or six-month term. Microdosing is not proven equivalent to standard-dose treatment.
Review IVIM's program detailsSources: Embody current product catalogue · IVIM Health microdosing programs and prices · FDA questions and answers on compounded drugs
Cost
First charge, renewal and commitment
Treatment
Medication, form and approval status
Care
Clinical review and ongoing support
Terms
Cancellation and material cautions
Choose IVIM for a dedicated lower-dose program
View Ivim Health termsSide by side
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | Embody | Ivim Health |
|---|---|---|
| Why each one | Publishes a complete four-tier price ladder for both molecules, so the commitment behind every advertised rate is checkable rather than implied. | Microdose programs offer two-, four- and six-month terms. Medication pricing and the separate $74.99 monthly program fee must both be included in the budget. |
| Last Published Score | 7.3/10 | 7.9/10 |
| Headline Price | from $69/mo | from $149.99/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | Yes |
| Best For | People who want to compare Embody's published plan menu with its separate monthly promotion and will confirm the exact charge, term and refund rules before paying | Users who want personalized dosing with frequent provider check-ins |
| Watch out for | Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date. | Once a program starts it cannot be cancelled. Ivim's GLP-1 ID page says cancellation is not available once your program has started, prescribed medication is non-refundable, and leaving early costs $100 for each undelivered three-month portion or $50 for each two-month portion |
| Get started | Visit Embody | View Ivim Health terms |
Compare the full bill, not just the advertised monthly number. These are published terms, not a personal prescription quote. We may earn a commission from marked partner links; other providers appear here for comparison. Scores use our last published assessment; source dates below distinguish price checks from that assessment. How our links work.
The $69 headline is not a flat verified checkout price. The public catalogue lists $79/$129 for one month and $69/$119 monthly equivalents on twelve-month prepay ($828/$1,428). A separate promotion advertises $69/$119 flat monthly, while the still-published April 24 terms list different introductory and fixed-price programs. Which terms apply to the final offer and renewal remains unverified. Sources checked September 27, 2026.
Compounded Semaglutide Injection (advertised plan floor): $79. Month-to-month rate. Public catalogue ladder checked 2026-09-20: $79 monthly, $76/mo on 3 months ($228), $73/mo on 6 ($438), $69/mo on 12 ($828). This row is the catalogue plan, not the separate offer described in the review.
Compounded Tirzepatide (GLP-1 + GIP) Injection (advertised plan floor): $129. Month-to-month rate. Public catalogue ladder checked 2026-09-20: $129 monthly, $126/mo on 3 months ($378), $123/mo on 6 ($738), $119/mo on 12 ($1,428). This row is the catalogue plan, not the separate offer described in the review.
Cancellation: Choose a 4-, 12-, 24- or 52-week plan at signup. Cancellation requests must reach support at least 72 hours before the next billing date, and the policy dated August 25, 2026 says all payments are final and non-refundable, with a refund for unused services on provider-determined medical disqualification, after deductions for services already provided. Multi-month plans are non-refundable in whole and in part. Refill orders triggered by user-completed optional refill intake can pull the next billing date forward.
Price source checked September 20, 2026. Confirm current eligibility, medication, term and total before paying.
Embody official pricing sourceMicrodose semaglutide from $149.99/mo equivalent: $75 medication on a four- or six-month program plus the $74.99 monthly program fee. Other protocols, medications and terms cost more; confirm the full commitment.
Monthly program fee: $74.99. Charged in addition to medication.
Microdose semaglutide (6-month program): $75. Monthly medication equivalent for the 6-month microdose program, plus the $74.99 monthly program fee. Confirm the total due and billing schedule.
Microdose semaglutide (4-month program): $75. Monthly medication equivalent for the 4-month microdose program, plus the $74.99 monthly program fee. Confirm the total due and billing schedule.
Microdose semaglutide (2-month program): $100. Monthly medication equivalent for the 2-month microdose program, plus the $74.99 monthly program fee. Confirm the total due and billing schedule.
Microdose tirzepatide (6-month program): $133. Monthly medication equivalent for the 6-month microdose program, plus the $74.99 monthly program fee. Confirm the total due and billing schedule.
Microdose tirzepatide (4-month program): $149. Monthly medication equivalent for the 4-month microdose program, plus the $74.99 monthly program fee. Confirm the total due and billing schedule.
Microdose tirzepatide (2-month program): $200. Monthly medication equivalent for the 2-month microdose program, plus the $74.99 monthly program fee. Confirm the total due and billing schedule.
Cancellation: No cancellation once a program starts. Ivim's GLP-1 ID page says cancellation is not available once your program has started, the returns policy says prescribed medication is non-refundable regardless of usage or cancellation, and the terms charge $100 for each undelivered three-month portion or $50 for each two-month portion on early exit
Price source checked September 10, 2026. Confirm current eligibility, medication, term and total before paying.
Ivim Health official pricing sourceScore evidence last assessed September 3, 2026.
Compounded medications are not FDA-approved; FDA does not review them for safety, effectiveness or quality before marketing. FDA's explanation of compounded-drug risks.
Trade-offs
Embody has the lower published one-month entry. Its catalogue lists one month of compounded semaglutide at $79 and tirzepatide at $129, including medication, clinical review, coaching and shipping. Twelve-month prepayment lowers the monthly equivalents to $69 and $119, but requires $828 or $1,428 up front. Start with the one-month figure when comparing the smallest commitment.
IVIM's microdose page lists semaglutide medication at $75 per month on four- or six-month programs and $100 per month on a two-month program. Its separate $74.99 monthly program fee brings those published monthly equivalents to $149.99 or $174.99. Microdose tirzepatide is listed at $133 per month on six months, $149 on four months or $200 on two months. With the program fee, the corresponding monthly equivalents are $207.99, $223.99 and $274.99.
IVIM presents these as monthly program amounts, but the public page does not settle every shopper's charge timing. Confirm the total due today, renewal date and full term before paying. A microdose price also cannot be treated as a quote for a standard-dose prescription.
Sources: Embody catalogue and plan terms · Embody plan-by-plan pricing · IVIM microdose price grid and program fee
Embody is the more direct match for a cash-paying shopper seeking a conventional compounded semaglutide or tirzepatide injection program. A clinician reviews the intake after checkout and decides whether a compounded prescription is appropriate. Embody's current catalogue does not publish a dedicated microdose tier.
IVIM markets its microdose program to people seeking a lower-dose start, weight-maintenance support or a more individualized dosing plan. That positioning is not evidence that microdosing works as well as an approved dose schedule or is safer for a particular patient. No large randomized weight-loss trial has established those outcomes for the commercial microdose protocols described here.
If microdosing is not the actual treatment goal, do not pay a longer-term program fee merely because the medication-only number looks low. Ask the clinician which molecule, dose and schedule fit your medical history first, then compare the complete price for that specific path.
Sources: Embody program and clinical review · IVIM explanation of its microdose program · GLP-1 Picks microdosing evidence guide
Embody's current catalogue is narrower. It lists compounded semaglutide and tirzepatide injections, with clinician review, coaching, messaging support, dose oversight and delivery in the program. It does not currently list an oral GLP-1 or an FDA-approved brand-name option.
IVIM has the broader treatment menu. Its microdose program includes a video consultation, individualized plan, weekly support, app access and other coaching features. Separate IVIM pathways advertise the brand-name Wegovy pill, Foundayo pill and brand-name injections. Those products have their own eligibility, dose and pricing structures, so their prices should not be substituted for the microdose-program totals above.
Choose breadth only when you need it. IVIM is more useful if you want to discuss lower-dose, oral and brand-name routes through one platform. Embody is simpler if a cash-pay compounded injection is already the agreed treatment path.
Sources: Embody current products and included care · IVIM microdose care features · IVIM Wegovy pill program · IVIM Foundayo pill program
Embody says the subscription begins when payment is made, before the clinician has completed the prescribing decision. Its policy makes paid plans normally non-refundable. If Embody's provider determines that you are medically disqualified, unused services may be refunded after services already provided are deducted. Other cancellations stop future billing and must reach support at least 72 hours before the next charge.
IVIM says an active membership is required for its medication program and that paying does not guarantee a prescription. Its returns policy says prescribed medication is nonreturnable and non-refundable. Its terms describe a possible refund for undelivered medication when ending a program early, less $100 for each undelivered three-month portion or $50 for each undelivered two-month portion; those fees are waived when IVIM determines medical ineligibility.
For either program, save the exact checkout terms. Confirm what is charged before clinical review, which amount is refundable if you do not qualify, and whether a longer term is paid monthly or in advance.
Sources: Embody refund and cancellation policy · IVIM medication-program terms · IVIM returns and refund policy
Embody has the lower published one-month cash-pay entry: $79 for compounded semaglutide or $129 for tirzepatide, including care and shipping. IVIM's lowest microdose semaglutide rate is $75 per month on a four- or six-month term plus a $74.99 monthly program fee, or $149.99 combined. These are different dose programs, so price alone does not make them clinically equivalent.
No. IVIM lists a separate $74.99 monthly program fee. The published combined monthly equivalent is $149.99 on its four- or six-month microdose semaglutide programs. Confirm the full charge timing and term at checkout.
IVIM offers separate brand-name oral pathways for Wegovy pill and Foundayo. Embody's current catalogue lists compounded semaglutide and tirzepatide injections and no oral GLP-1. Pill eligibility, dose and price require their own clinical review.
No. Compounded semaglutide and tirzepatide are not FDA-approved finished products and are not generic versions of approved brands. IVIM also offers separate FDA-approved brand-name pathways, which should not be confused with its compounded microdose programs.
Start with Embody if a clinician-supported compounded injection is your intended path and you want the lower one-month commitment. Consider IVIM if a clinician agrees that its dedicated microdose program or broader oral and brand-name menu solves a specific need. Compare the total fee, term and refund rules for the exact pathway before paying.
Keep narrowing the decision
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
More head-to-head comparisons involving Embody and Ivim Health.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Embody legit, with the verification evidence behind each answer.
